1 week Ago By ABMN Staff
Prudential Financial Inc. lessened its position in shares of Bruker Co. ( NASDAQ:BRKR – Free Report ) by 40.
9% during the 4th quarter, HoldingsChannel reports. The fund owned 5,687 shares of the medical research company’s stock after selling 3,930 shares during the quarter. Prudential Financial Inc.
’s holdings in Bruker were worth $333,000 at the end of the most recent quarter. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Eagle Bay Advisors LLC lifted its position in Bruker by 2,324.
1% during the 4th quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 674 shares during the period. UMB Bank n.
a. raised its stake in shares of Bruker by 37.5% during the fourth quarter.
UMB Bank n.a. now owns 909 shares of the medical research company’s stock worth $53,000 after buying an additional 248 shares during the last quarter.
GAMMA Investing LLC lifted its holdings in Bruker by 47.5% in the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after buying an additional 412 shares during the period.
EverSource Wealth Advisors LLC boosted its stake in Bruker by 41.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,330 shares of the medical research company’s stock valued at $78,000 after acquiring an additional 390 shares during the last quarter.
Finally, Blue Trust Inc. grew its holdings in Bruker by 13.5% during the 4th quarter.
Blue Trust Inc. now owns 2,164 shares of the medical research company’s stock worth $127,000 after acquiring an additional 257 shares during the period. 79.
52% of the stock is currently owned by institutional investors and hedge funds. Analyst Upgrades and Downgrades Several research firms have recently issued reports on BRKR. Guggenheim restated a “buy” rating on shares of Bruker in a research report on Monday, February 24th.
Citigroup reduced their target price on Bruker from $75.00 to $50.00 and set a “buy” rating on the stock in a report on Monday.
Barclays decreased their target price on Bruker from $60.00 to $50.00 and set an “overweight” rating for the company in a research report on Thursday.
Stifel Nicolaus reduced their price objective on shares of Bruker from $70.00 to $57.00 and set a “hold” rating on the stock in a research note on Friday, February 14th.
Finally, Bank of America upped their target price on shares of Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Friday, December 13th.
Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $66.
50. Bruker Stock Down 7.6 % Bruker stock opened at $38.
07 on Friday. The company has a 50 day moving average of $46.51 and a 200-day moving average of $54.
95. The company has a quick ratio of 0.77, a current ratio of 1.
60 and a debt-to-equity ratio of 1.15. Bruker Co.
has a twelve month low of $34.10 and a twelve month high of $90.56.
The stock has a market capitalization of $5.78 billion, a PE ratio of 50.09, a price-to-earnings-growth ratio of 2.
16 and a beta of 1.18. Bruker ( NASDAQ:BRKR – Get Free Report ) last announced its earnings results on Thursday, February 13th.
The medical research company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.75 by $0.
01. Bruker had a net margin of 3.36% and a return on equity of 21.
01%. On average, equities research analysts anticipate that Bruker Co. will post 2.
69 EPS for the current fiscal year. Bruker Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Monday, March 17th were given a $0.
05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.
53%. The ex-dividend date was Monday, March 17th. Bruker’s dividend payout ratio is presently 26.
32%. Bruker Company Profile ( Free Report ) Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Featured Stories Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. ( NASDAQ:BRKR – Free Report ).
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter ..
